The source magazine

The Fall 2026 issue of THE SOURCE, the magazine of the Plasma Protein Therapeutics Association (PPTA), explores the people, partnerships, policies, and initiatives shaping the global plasma community. With a focus on plasma awareness, patient access, advocacy, regulatory collaboration, and the people behind plasma donation, this issue highlights: • Regulatory collaboration and innovation, including an in-depth look at the European Medicines Agency’s Product Management Service (PMS) and how industry expertise is helping shape a more harmonized and efficient regulatory environment. • The evolving healthcare policy landscape, including how the 2026 U.S. midterm elections and potential changes in Congress could affect drug pricing, reimbursement, supply chains, and access to plasma-derived medicines. • Advocacy and engagement, spotlighting PPTA’s Congressional Fly-In and efforts to bring the voices of patients, donors, manufacturers, and advocates to Capitol Hill. • Global supply resiliency, including the Plasma Project in Brazil and efforts to build greater awareness of plasma’s essential role in immunoglobulin production and strengthen long-term supply security.

In this issue: PPTA Publishes Seminal Review Articles on the History of Plasmapheresis and Plasma-Derived Medicinal Products; Managing Media Narratives: Insights from Supporting the Plasma Industry; Record Momentum and Scientific Excellence: IPPC 2026 in Milan Sets a New Benchmark; Share Your Voice: New Global Patient Survey; the European Plasma Alliance Welcomes New Chair; Strengthening the Plasma Community: Welcoming a New Member; Plasma-Derived Therapies: Preserving Access, Protecting Patients; PPTA Urges Plasma-Derived Medicines Exemption from CMS Proposed Pricing Models, and more

In this issue: Global regulatory harmonization in the spotlight in Shanghai; Industry implementation proven to protect donors; Associations between frequent plasmapheresis, biomarkers, and health outcomes: A 2-year national prospective Cohort of Repeat Donor Experiences (CORE) study; Journeys of career growth in the plasma industry; European Medicines Agency's recommendations to boost supply or anti-D immunoglobulin; High-level discussion in Brussels highlights need for tailored approaches to Critical Medicines, and more.

In this issue: Creating Community: Grifols Annual Box Out Hunger Food Drive; CalPlasma Makes an Impact in Sacramento; Plasma Pathways: Journeys of Career Growth; Weathering the Storm: Keeping the Plasma Industry Supply Chain Moving; Expanding Lifesaving Access to Care: Uzbekistan Starts Plasma Collection; What Does it Mean to be Both a Caregiver and Advocate? An Interview with Heinz Stutzenberger, and more!